Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Adrenal disorders and the paediatric brain: pathophysiological considerations and clinical implications.
CLINICAL PROBLEM-SOLVING. A Breakthrough Diagnosis.
Acute Disseminated Encephalomyelitis Without Optic Neuritis Followed by Optic Neuritis in a Child Due to the Sudden Cessation of Steroid Therapy.
Treatment Against Human Endogenous Retrovirus: A Possible Personalized Medicine Approach for Multiple Sclerosis.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Comment on: Evolution of multiple sclerosis in France since the beginning of hepatitis B vaccination.
Simplified scoring of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis: a comparative analysis of test performance at different cut-off points.
Clinical pharmacology of ponesimod, a selective S1P1 receptor modulator, after uptitration to supratherapeutic doses in healthy subjects.
Fully automated open-source lesion mapping of T2-FLAIR images with FSL correlates with clinical disability in MS.
Menopause in multiple sclerosis: therapeutic considerations.
Role of Tumor Necrosis Factor Superfamily in Neuroinflammation and Autoimmunity.
Changing associations between cognitive impairment and imaging in multiple sclerosis as the disease progresses.
DTI detects water diffusion abnormalities in the thalamus that correlate with an extremity pain episode in a patient with multiple sclerosis.
Possible second motor neuron damage in neuromyelitis optica.
Switching therapies in MS: what are the options?
Self-reports of executive functioning in multiple sclerosis: to trust or not to trust.
Effect of Fingolimod on Platelet Count Among Multiple Sclerosis Patients.
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.
Current and emerging therapies for the treatment of multiple sclerosis: focus on cladribine.
Differential diagnosis of Mendelian and mitochondrial disorders in patients with suspected multiple sclerosis.
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis.
ShcA Regulates Late Stages of T Cell Development and Peripheral CD4+ T Cell Numbers.
Relative incidence of inherited white matter disorders in childhood to acquired pediatric demyelinating disorders.
Urinary complications and risk factors in symptomatic multiple sclerosis patients. Study of a cohort of 328 patients.
Emerging stem cell therapies: treatment, safety, and biology.

Pages